Gavreto
| Gavreto | |
|---|---|
| Term | Gavreto |
| Short definition | gavage (guh-VAZH) A method of administering drugs and liquids, including liquid foods, through a small tube inserted through the nose or mouth into the stomach or small intestine. Sometimes the tube is inserted into the stomach or small intestine through an incision (cut) on the outside of the abdomen. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Gavreto - (pronounced) (gav-REH-toh) A drug used to treat adults with non-small cell lung cancer that causes aRET fusion gene and adults and children 12 years and older with certain types of thyroid cancer, including medullary thyroid cancer, that aRET fusion gene or a mutation (change) in the RETG gene. It is used in patients whose cancer is advanced or has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Gavreto blocks certain proteins made by the RETF fusion gene, or the mutated RETG gene, which can help stop cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called pralsetinib
External links
- Medical encyclopedia article on Gavreto
- Wikipedia's article - Gavreto
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski